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Chapter 1: Background Information on HIV-Vif
Intrinsically disordered proteins (IDP) are proteins that do not follow the traditional
protein structure paradigm, which states that the function of the protein is dependent on the
stability of its structure thermodynamically. IDPs are structurally dynamic and do not contain
any tertiary structure yet they are responsible for many biological functions like cell signaling
and regulation (Wright and Dyson, 2015). Alone, they do not fold spontaneously into a stable
structure and instead fluctuate through more conformations than folded proteins (Dyson, 2016).
IDPs have specific characteristics related to their flexibility that allow them to perform specific
functions. For example, they contain small recognition elements that fold upon partner binding,
their flexibility allows them to interact with different targets on different occasion, and they
efficiently utilize conserved sequence motifs to mediate binding interactions (Wright and Dyson,
2015). The folding of many IDP proteins revolves around their ability to create protein-protein
interactions, and therefore, studying their interactions with other proteins is important for
understanding their biological functions. Since they mediate many cellular functions and
participate in human diseases and infections, there is a necessity to find ways to characterize
their dynamics and intermolecular interactions.
Human Immunodeficiency Virus Viral infectivity factor (HIV Vif) is an intrinsically
disordered protein that aids the survival of HIV in the human body. HIV attacks the immune
system’s T cells, decreasing the body’s ability to fight off infections and other diseases and
causing patients to become more susceptible to other diseases. Currently there is no cure but
there are medical treatments to control the disease. HIV uses the host cell’s ability to ubiquinate
and degrade proteins on antiviral proteins. HIV Vif hijacks the ubiquitination mechanism to aid
HIV spreading through the body. Understanding how the Vif protein functions could aid in
understanding how IDPs interact with other proteins and lead to a potential drug target to stop
the spread of HIV.
The Vif protein mediates the breakdown of antivirals by binding the apolipoprotein B
mRNA-editing enzyme, catalytic polypeptide-like 3 (APOBEC3) antiviral enzyme to Cullin 5
(Cul 5) (Figure 1). Without Vif present, APOBEC3 can interact with HIV virions and inhibit
viral replication with its deaminase activity (Richards et al., 2015). Deamination is the process of
removing an amine group from a molecule and so it turns cytidines to uridines in the viral DNA.
This causes a hypermutation that makes the viral infection nonproductive (Richards et al., 2015)
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APOBEC proteins help to protect the human body from foreign infections; however, the process
is prevented by Vif, which tags APOBEC proteins with ubiquitin, leading to their degradation
and therefore the propagation of HIV through the body. Vif affects APOBEC3D, E, F, G, and H
members of the APOBEC3 family making it a protein necessary for HIV to thrive in the body
(Lu et al., 2013).

Figure 1. Role of APOBEC proteins in propagation of HIV through host cells when Vif is
and is not present. Figure reproduced from Cullen, 2003.
Vif is an intrinsically disordered protein and so it needs to interact with other proteins to
adopt a folded structure and to breakdown APOBEC proteins. The structure is important to the
function of the protein complex because it determines the interface of protein-protein binding
interactions, the stability of the complex, the conformation, and the overall surface charge
(Alberts et al., 2002). Theses structural characteristics will define how a protein interacts with its
environment. When Vif is inside host cells, it will bind to the proteins Elongin B (EloB) and
Elongin C (EloC) at its C-terminus and to Core binding factor  (CBF-) at its N-terminus
(Evens et al., 2014). CBF- primarily stabilizes Vif to allow for the binding of APOBEC
proteins (Guo et al., 2014). EloB, EloC, and Cullin 5 (Cul5) bind to Vif to create an E3 ubiquitin
ligase complex. E3 ubiquitin ligase complexes exist in the body naturally and are responsible for
degrading proteins that are no longer needed (Lui and Nussinov, 2010) (Figure 2). The Vif
complex is only active once all proteins are bound together and an APOBEC protein substrate
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can bind to Vif.
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Figure 2. a) Normal E3 Ubiquitin ligase complex in healthy host cells. RBX2 is another protein
that binds the ubiquitin proteins to Cul5 via a E2 enzyme. The suppressors of cytokine signaling
(SOCS)2 protein is adapter protein that connects the substrate protein to Cullin 5 (Lui and
Nussinov, 2010). b) Vif hijacked ligase complex in HIV Vif+ host cells.
Understanding how this complex behaves in the body can help give better understanding
of how to treat HIV since Vif is essential for HIV survival in cells (Guo et al., 2014). Protein
complexes such as the VCBC complex sample different conformations some more favorable
than other conformations. Looking at conformations and degree of conformational sampling
reveals structure and therefore functional properties of the VCBC complex. Conformations more
favorable for Vif binding to APOBEC that allow Cul5 to wrap around and attach the ubiquitin to
the APOBEC antiviral could be important for developing a therapeutic treatment.
The binding of Vif to host cell proteins allows Vif to function. Vif interacts with four
different host cell proteins in order to fold: CBF-, Cul5, EloB, and EloC. The crystal structure
for the Vif-CBF--CUL5-ELOB-ELOC (VCBC-Cul5) complex has previously been solved
(Guo et al., 2014). Vif can be split up into a larger (/) domain and a smaller () domain that
are connected through a linker region containing a coordinated zinc ion (Guo et al., 2014). The
crystal structure found experimentally shows that Vif’s zinc-finger motif, which forms a
tetrahedral interaction with a zinc ion, is important for adding stability to the domains (Guo et
al., 2014). The zinc ion interacts with the HCCH arrangement of His and Cys residues on the Vif
protein (Costa et al., 2014). This coordinates the Vif linker region and mutations to this region
affect the binding of Cul5 (Evans et al., 2014). CBF- binding is necessary to facilitate Vif
folding and nucleation of the rest of the E3 ubiquitin ligase complex (Jager et al., 2011). There
are many motifs in Vif that aid in its ability to bind to other proteins. The N-terminal peptide of
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Vif forms an antiparallel -sheet with -strand S3 from CBF-. CBF- stabilizes the two loosely
packing helices that make up the -domain of Vif through binding. The -domain of Vif
contains the BC-box motif which is required for the interactions with EloB-EloC and Cul5. This
interaction is similar to that seen of the SOCS-box motif in SOCS-box proteins (Guo et al.,
2014). The similarity between the Vif BC-box motif and SOCS protein allow for Vif to hijack
the E3 ubiqutin ligase complex since it can take on similar conformations to function as a ligase.
Cul5 is responsible for attaching ubiqtuitin to APOBEC and so if it is not bound to the VCBC
complex, there will be no degradation of APOBEC. Cul5 interacts with Vif through the helix 3
and the following loop of residues 116-131(Guo et al., 2014). Cul5 also interacts with EloC but
not EloB. These specific interactions keep Cul5 and CBF- bound to Vif giving this IDP more
stability and structure.
Previous to the VCBC-Cul5 crystal structure, a slightly different model for Vif binding to
EloB and EloC was proposed (Bergerson et al., 2010). It was observed that as EloBC binds with
the Vif SOCS-box, the region folds (Marcsisin and Engen, 2010). Through multiple NMR
structures of 36 residues of Vif, EloB and EloC by Bergerson et al., two motifs were found to
facilitate binding between these proteins. The Vif SOCS-box goes through a conformational
change to form an -helix which binds EloC through hydrophobic interactions (Bergerson et al.,
2010). Another motif is the Pro-Pro-Leu-Pro (PPLP) motif of Vif which is seen to contribute to a
hydrophobic interface for Cul5 and EloC binding (Bergerson et al., 2010). This PPLP has also
been seen to interacts with residues 101-104 of the C-terminus domain of EloB (Lu et al., 2013).
The interaction between the -helix of EloC and Vif drives the folding of Vif causing the PPLP
motif of Vif to interact with EloB. This weak interaction is driven by van der Waals forces, but it
induces a conformational change from an unstructured to a structured state. This is important for
the recruitment of CBF- binding and degradation of A3G (Lu et al., 2013). Lu et al. suggests
that this interaction could be used to make a new class of anti-HIV drugs. The other crystal
structure that has been solved contains all of Vif, CBF-, EloC, a truncated EloB, and part of
Cul5 (Guo et al., 2014). This article does mention the SOCS box interactions with EloB and
EloC however it does not state any interactions occurring between EloB and the PPLP motif
(Guo et al., 2014) We used the Guo et al. crystal structure since it is more complete for our
research. We have shown that the PPLP motif and EloB interaction did not appear in our
simulations and therefore the Lu et al. article may have only seen this interaction due to the use
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of an incomplete Vif structure.
The structure of the VCBC-Cul5 complex has been solved by x-ray crystallography (Guo
et al., 2014). Methyl-TROSY NMR was completed by our lab through labeling the methyl peaks
of specific amino acids –valine, isoleucine, leucine, alanine, methionine—of the backbone
carbon(C) and the hydrogen attached (H). Specific amino acids, IVLMA, were labeled and
compared to learn about conformational sampling on the ms-sec timescale causing peak
broadening from the intermediate conformational exchange. NMR of the VCBC-Cul5 protein
complex was attempted but the data was not well resolved which could be due to the complex
being too large. VCBC without Cul5 was expressed and a spectrum was found; however, there
were very little methyl peaks that appeared on the spectrum. The crystal structure of VCBC-Cul5
is missing 16 residues on the C-terminus of EloB (Guo et al., 2014). A construct containing these
16 residues was expressed and the new protein complex produced a better signal with more
methyl peaks in the NMR spectra. This led to a more in-depth comparison of the VCBC Guo et
al. crystal structure (VCBC truncated) compare to VCBC with the full-length EloB structure
(VCBC) to understand why the spectra were so different. We predicted that with the 16 residues
the structure was more stable and therefore the NMR showed more methyl peaks.
Characterizing IDPs in different conformational states more challenging since most
experimental methods used, like NMR and crystallography, take an average of the overall
structure. However, using computational methods to model the protein motions and interactions
atomic level detail of any VCBC complex can be studied. When taking the NMR signal from a
protein, this gives an average over time of a protein conformation. Using Molecular Dynamics
(MD) simulations, the individual conformations of the protein can be modeled. All
computational data must be compared to experimental results to conclude a certain model is
realistic and reasonable to use for the protein complex.
MD is useful for determining different conformations of proteins and the transitions
between the conformations. This is helpful for understanding flexible protein complexes that
change conformations over time because it can capture different conformations in free energy
landscapes and see how flexible a protein is (Pecora de Barros et al., 2017). Combining
experimental data and MD simulations is helpful for creating a model of a protein at the atomic
level that would be a realistic model in vivo (Perilla et al., 2017).
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In Chapter 2, NMR spectra are analyzed to compare the number of available peaks that
differ between spectrums of VCBC, truncated VCBC, and VCBC bound to APOBEC3F (A3F)
and our attempt to assign all the peaks. Our NMR experimental data was collected by Prof.
Aurelia Ball. Looking at the spectra of the VCBC complex with and without A3F, shows us that
the VCBC complex with A3F (VCBC-A3) gave a clear signal with more methyl peaks
appearing. This could be due to the decrease in exchange occurring on the intermediate time
scale. We also try to identify the different peaks that appeared in our spectra and what type of
residue they were. Using a python package called NMRglue, I labeled peaks by protein and
residues type after generalizing what type of residue would appear in which area of the spectra. I
also compared the VCBC truncated NMR spectrum to the VCBC NMR spectrum and saw that
the VCBC spectrum has a clearer signal and produced better NMR results.
Our NMR results led us to run MD simulations of the VCBC truncated structure, and
VCBC in Chapter 3. We ran simulations of VCBC truncated and VCBC to analyze why the
NMR experimental data showed differences when a small primary structural change was made to
the protein complex through the addition of 16 residues to the C-terminus of EloB. All these
proteins are necessary for the E3 ubiquitin ligase complex to be activated so it is important to
characterize the conformational sampling. Each of these simulations were analyzed in our lab
using different analysis techniques. The primary method for characterizing global
conformational sampling was Principle Component Analysis (PCA). PCA separates the motions
of the protein complex into correlated global motions and unessential motions. PCA allows us to
represent protein conformations as vectors that cover the motions of a molecular structure over
time (David and Jacobs 2014). Each principle component represents one global motion and by
projecting the protein complex trajectories onto them, we can visualize how the protein complex
is moving. This gives us a qualitative way to characterize the global conformational sampling.
Between VCBC truncated and VCBC there was about the same degree of conformational
sampling along PC1 and PC2.
Chapter 4 discusses how we showed that the results we found were statistically
significant. To test if our simulations of VCBC are run for enough time for the constructs to
sample completely through their free energy landscape, the root-mean-squared deviation
(RMSD) and radius of gyration are measured over the simulations. The running average of both
RMSD and radius of gyration was calculated. As the average of each simulation converged over

8

time, the distance between the atoms and the movement of the protein relative to its center of
mass show when they are no longer sampling new local conformations. This indicates that the
VCBC simulations have been run long enough to sample most conformational state that it would
exhibit. We used PCA on VCBC truncated, VCBC, VCBC-A3F, and VCBC-Cul5 construct 100ns blocks to observe how the sum of the top 5 PCs changes as the simulations run. This
represents how the variation of how much global correlated motions is within the top 5
eigenvectors. From this we say that the last 300 ns of all simulations gave similar variance of the
global motions and therefore the last 300ns will be used for all analysis methods. Sigma-R plots
were to show equilibration of independent simulations over time through viewing that the
simulations 100ns blocks are the same for each construct. To test if our PCA values were
significant, we used the Kolmogorov-Smirnoff p-values to show that the projection of VCBC
and VCBC-Cul5 on their combined eigenvectors is significantly different. Other constructs like
VCBC truncated and VCBC-A3F are plotted on the combined eigenvectors but it is observed
that the p-values found are not as useful to us since the eigenvectors are not completed using
these construct trajectories.
In the final chapter, Chapter 5, VCBC is mutated (mutant VCBC) to observe any changes
in global or local conformations that could lead to a potential drug target. In Vif, residue 25,
which is a valine, was mutated to an alanine. Simulations were run with this mutation and
through running averages of radius of gyration, we conclude that the simulations need to be run
for longer since not all possible conformations had been sampled yet form the free energy
landscape. Preliminary results show through PCA and atomic fluctuations that the VCBC mutant
sampled similar degrees of global correlated motions and local atomic flexibility to VCBC-Cul5.
However, more independent simulations and continuous simulations need to be completed before
any definitive results can be concluded.
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Chapter 2: Experimental NMR Analysis
Nuclear Magnetic Resonance (NMR) is a technique that can be used to discover the
structure of compounds. Most protein structures are found using NMR or x-ray crystallography.
NMR depends on the intrinsic quantum property of the nucleus, the spin. When the nucleus is in
an applied magnetic field, the spin will either aligned or spin opposite direction. The
electromagnetic radiation can flip the spin orientation compared to the magnetic field and this
spin-flip has a change in energy. This change of energy is related to the Larmor frequency, which
is the frequency at which the magnetic dipole precesses around the x-y plane due to the applied
magnetic field. An NMR spectrum is a plot of the radio frequency applied compared to the
absorption. The chemical shift is the difference between the Larmor frequency and the measured
frequency. Using regular NMR to find structural and dynamic information on macromolecules is
difficult because of poor peak dispersion, spectral crowding, and especially line broadening
because of rapid transverse relaxation of nuclear magnetization (Clark et al., 2015).
NMR can be used to study the structure of proteins and their dynamics using a specific
type method called methyl transverse relaxation optimized spectroscopy (TROSY). Methyl
TROSY NMR used destructive interference between relaxation mechanisms to create spectra
with improved resolution (Ollerenshaw et al., 2003). Labeling the 1H and 13C of methyl groups
in selected amino acids allows for producing NMR spectra of protein samples (Ollerenshaw et
al., 2003). Methyl groups are useful spectroscopic probes because they are found throughout a
folded protein core and the resonance of these groups are intense and well dispersed (Clark et al.,
2015). Relaxation due to 1H-1H and 1H-13C dipolar interactions are slow for macromolecules
which is why TROSY experiments work well for proteins. In methyl systems, there are low
relaxation rates because of destructive interference between dipolar relaxation interactions. This
can be used to create 1H-13C correlation maps to identify specific amino acids in a protein
(Ollerenshaw JE et al., 2003). This method has been used to label eukaryotic protein actin
successfully through 13C isoleucine δ1-methly labeling (Clark et al., 2015). Another article
observed the catalytic domain of ABI kinase through 1H-15N labelling in inset cells (Strauss et
al., 2005). This method of analyzing the dynamics of proteins has been used in many
experiments to identify the structure and dynamics of protein domains and the therefore was used
by our lab to compare the dynamics of the VCBC complex.
Methyl-TROSY NMR was completed on three protein complexes. The crystal structure
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for VCBC-Cul5 was solved for but 16 residues on the C-terminus of EloB were not included
(Guo et al., 2014). The structure of the full-length EloB, EloC and half of the Vif protein (36
residues) was solved for (Lu et al., 2013). NMR experiments were completed on VCBC with the
full length EloB and with truncated EloB C-terminus. NMR of the VCBC-A3F complex was also
completed to compare the dynamics of when A3F is bound to the VCBC complex verses when it
is not. NMR data was not collected of the VCBC-Cul5 complex due to the Cul5 protein being to
larger.

Methods
Methyl-TROSY NMR of the 13C-ILVMA-labeled VCBC complex was collected with the
VCBC protein complex bound to single-stranded DNA. This selective labeling on specific amino
acids allows for a reduction of peaks on the spectrum to decrease overlapping peaks. The VCBC
complex tends to aggregate and precipitate out at high concentrations which are needed for
NMR. To overcome this issue, the complex was bound to 14-T repeat of single-stranded DNA
(dT14) to allow the experiment to be done under low-salt conditions (20 mM NaCl) and stopped
the broadening of individual methyl peaks. The DNA helped to shield the positive surface charge
of Vif from electrostatic interactions with other Vif complexes in solution.
The NMR spectroscopy was completed in 20 mM HEPES buffer at pH 7.5with 20 mM
NaCl and 0.5 TCEP. An 800 MHZ Bruker spectrometer with a cryogenically cooled probe was
used to perform NMR at 300K (Tugarniov, 2006). In the VCBC-dT14 experiments, the
concentration of VCBC was 160 M VCBC and completed with 256 scans in the 1H
dimension. For the VCBC-dT14-A3Fctd experiments 816 scans were done in the 1H dimension,
and the concentration of A3Fctd was 108 M and for VCBC was 90 M. Each of the spectra
were processed using NMRPipe program (Delaglio 1995).
The figures and chemical shift assignments were done using python module NMRglue
(Helmus et al., 2013). Picking peaks was completed using the NMRglue package. Many peaks
that overlapped were taken out and some were added in that were not picked through NMRglue
for the NMR spectra with A3F in solution. The peaks were also adjusted to fit the spectra more
easily which was applied to all peaks evenly to ensure the relationship between peaks remains
the same.
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Results
Using Methyl-TROSY NMR the VCBC complex dynamics can be analyzed when adding
other residues or proteins. The spectrum shows specific methyl peaks while other peaks
disappear due to broadening of peaks. These broadened peaks are due to global conformational
changes that occur on the intermediate NMR exchange timescale which is between milliseconds
and seconds for macromolecules like proteins (Mittermaier and Kay, 2006).
When comparing the VCBC with full length EloB complex and the VCBC-A3F complex
NMR spectra, more individual methyl peaks were seen when A3F was present (Figure 3). In the
VCBC-A3F complex, A3F was not labeled; therefore, all methyl peaks were from VCBC for
both spectra. The disappearance of peaks is due to less exchange on the intermediate timescale
and since there is less conformational sampling, more peaks will appear. We see that VCBC-A3F
is a more stable protein complex due to more peaks being visible on the NMR spectra.

Figure 3. Overlayed NMR spectra where the red is with A3F and the black was VCBC without
A3F.
Since the VCBC-A3F spectrum contained more peaks, each peak is labeled with a dot to
identify singular peaks that can possibly be assigned to a particular amino acid in a protein of the
VCBC-A3F complex (Fig 4). A total of 152 peaks were picked out of the VCBC-A3F spectrum
that could each correspond to an ILVMA amino acid.
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Figure 4. Picked peaks of the VCBC-A3F NMR spectra completed using the python library
NMRglue.

Figure 5. Picked peaks of the VCBC NMR spectra completed using the python library NMRglue.

In the VCBC complex, there are 194 ILVMA-type of amino acids that could possibly
appear on the VCBC NMR Spectra. However, since there were not that many peaks picked on
the VCBC-A3F spectra, it is likely some of the peaks were overlapped especially in the central
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section of the spectra. There are likely many peaks in this region that cannot be individually
identified. The loss of peaks could also be due to exchange on the intermediate timescale causing
some amino acids in more flexible regions of the protein to disappear. The average signal of a
flexible region of the protein will flatten out and not appear at this contour level height.
With the peaks that we were able to pick out of the spectra, we tried to identify which of
the peaks were from specific proteins in the protein complex. Looking through the BMRB
database, most of the ILVMA methyl groups have published resonances; however, no peaks of
these specific types of amino acids were published of Vif (Table1). The EloB and EloC peaks
came the Lu et al. NMR structures; however, none of the Vif peaks that were labeled in our
spectra had respective chemical shifts published in the article (Lu et al., 2013). The CBF- peaks
came from a separate NMR structure that was independent of other proteins (Huang et al., 1998).
Some of the peaks correspond with the picked peaks on the VCBC and VCBC-A3F spectra
(Table 1). More peaks were present that corresponded with ILVMA peaks in the VCBC-A3F
spectrum compare to the VCBC spectrum.

Table 1. Methyl groups in the VCBC spectra that match published resonances.

Protein

# of ILVMA
methyl groups

Vif
CBF-β
EloB
EloC

88
60
24
22

# of ILVMA
methyl groups
with published
resonances
0
56
24
22

# of the
published
ILVMA
resonances in
VCBC-dT14
spectrum
0
21
1
2

# of the published
ILVMA
resonances in
VCBC-dT14A3Fctd spectrum
0
45
9
9

We plotted the published peaks of EloB, EloC, and CBF- onto our VCBC-A3F
spectrum to identify which peaks on the spectra corresponded with the specific VCBC proteins
(Figure 6). When placing where peak locations were of each protein from published NMR
chemical shifts, only a small number of EloB and EloC peaks corresponded to peaks on the
VCBC-A3F spectrum.
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Figure 6. Labeled amino acids from published NMR peaks for CBF-, EloB, and EloC placed on
top of VCBC-A3F spectra.
When comparing the database peaks to the picked peaks of the VCBC-A3F spectrum,
most peaks could not be identified for which protein it belongs to. There is no specific region of
the spectrum that each protein contains amino acids independently from the others. Amino acids
from each protein are mixed throughout the spectra. Then, we colored the dots by their ILVMAtype of amino acid to try to specify the amino acid type for each peak.
Using the BMRB database, the chemical shifts for the labeled carbons and hydrogens for
ILVMA amino acid regions were highlighted to identify the amino acid that corresponded with
each peak (Figure 4). However, due to the major overlap of chemical shifts for the amino acids it
is difficult to define each peak to a specific amino acid type. Instead, the different regions of
where ILVMA give us an idea of which residues overlapped and which would be more readily
countable.
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Figure 7. VCBC-A3F NMR spectrum with picked peaks of NMRglue package in blue with the
regions of peaks for specific amino acids would appear were colored accordingly.
From the spectras, it was seen that the Isoluecines were probably the easiest to count
compare to the others since there was not as much overlap with other residue types. There were
18 peaks in the Ile-C region of the VCBC-A3F spectrum. However, in the VCBC spectrum only
2-3 peaks appeared in the same region. This supports that more broadening of peaks occurred in
the VCBC spectrum like due to the reduced conformational exchange on the intermediate
timescale for the VCBC-A3F protein complex.
The NMR spectrum with the truncated EloB in the VCBC complex contained fewer
peaks. This was likely due to conformational sampling occurring at a intermediate timescale that
could not be captured by NMR. However, by including the full-length tail of EloB, a small
primary structure change of an additional 16 more residues, the NMR spectra improved and
more methyl peaks were present. This is possibly due to the added stability to the complex using
the full 118 residues in EloB.
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Figure 8. Overlay NMR spectra of VCBC truncated in black and VCBC in red. The full-length
EloB C-terminus allows for better NMR spectra of the VCBC complex
The extra 16 residues on EloB affected the NMR signal so that more methyl peaks, each
representing a single amino acid, could be identified. The full-length tail quenches more
dynamics and less global conformational sampling to decrease the broadening and dissapearance
of methyl peaks. We explore this primary structural change through the use of computations MD
simulations to understand how a small primary strcural change could possibly affect global
conformational sampling. Simulations of both VCBC complex structures including the full
length EloB C-terminus and truncating EloB were compared using different analysis methods.

Discussion
Between the VCBC and VCBC-A3F spectra, more peaks were observed when A3F was
bound to the VCBC complex. More singular peaks were picked from the VCBC-A3F spectrum
that corresponed to ILVMA published peaks. Through trying to identify and label each peak to
specific proteins and amino acid types, we learned it was difficult to pick out each peak through
the methods of comparing our specra to other known chemical shifts for specific residues in
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published protein databases for ELoB, ELoC, and CBF-. Sprangers and Kay in 2007 were able
to identify and quantify specific domains of a 20S proteosome that might facilitate substrate
localization to the catalytic chamber and modulate interactions of the nuclear localization-type
signal with receptors. They were also able to gain insight into the function of the proteasome due
to the mapping of one of the binding sites (Spranger and Kay, 2007). They were able to use
Methyl-TROSY NMR with nuclear Overhaouse effect (NOE) to observe the dynamics of the
proteosome and label each methyl peak on the spectra. Being able to do this for the VCBC
complex would be helpful to also understand how VCBC modulates interactions with APOBEC
proteins and give insight to how VCBC functions. Finding new methods for assigning all the
peaks in the VCBC-3F spectra will be necessary for us to assign our spectra and give more
quantitative differences on conformational differences between VCBC and VCBC-A3F.
Comparing VCBC with the extra 16 residues on the C-terminus of EloB and without
made it necessary to gather more atomic level detail to understand why there was an increase in
methyl peaks when the only change was a small primary structural difference. If the change
caused a decrease in conformational sampling on the intermediate timescale, it leads us to
believe that VCBC with the full-length EloB is a more stable structure and therefore this VCBC
complex could be used to compare when other proteins like A3F or Cul5 are added to the
structure instead of the crystal structure version of EloB. In the next chapter, MD simulations
were run for both starting structures to look at global and local conformational sampling that
distinguish the two structures.
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Chapter 3: VCBC inclusion of full length C-terminus in EloB
From, previously run NMR experiments (chapter 2), we observe that there is a difference
in exchange occurring on the intermediate timescale due to a small primary structure change in
EloB. Experimentally, the NMR spectra of the VCBC complex with the truncated EloB
contained fewer individual methyl peaks. However, when EloB contained its full C-terminus tail,
a better spectrum was produced with more peaks appearing. From the crystal structure of VCBCCul5 that was solved, EloB is missing 16 residues off the C-terminus end of the protein (Guo et
al., 2014). However, other scientists have solved the structure of the full EloB with EloC and
part of Vif through NMR spectroscopy (Lu et al., 2013). Adding in the 16 residues into our
VCBC simulations could affect the VCBC complex.
EloB interactions with EloC and Vif allow for Vif to gain structure and bind to APOBEC
proteins through the necessary interactions. The N-terminus (UBL domain) of EloB binds to
EloC and the COOH-terminal tail of EloB binds to the PPLP motif of Vif in a crystal structure of
part of Vif, EloB, and EloC (Lu et al., 2013). Also seen through cell assays, the PPLP motif
binds to EloB for the formation of functional complex (Bergeron et al., 2010). These interactions
can induce a structural change in Vif that facilitates Vif's interactions with both Cul 5 and CBF-
(Lu et al., 2013). The EloB C-terminus tail has been proposed to improve Vif function and could
be a possible drug target (Wang et al., 2013). Through mutating EloB to be missing 34 residues
of the C-terminus tail, the interaction between Vif and CBF- was impaired (Wang et al., 2013).
The C-terminus of Vif is responsible for interacting, stabilizing, and assisting in folding of
proteins of the SOCS family (Bullock et al., 2006 and 2007). Vif contains a SOCS-box that is
responsible for binding to EloB on the C-terminus (Kamura et al., 2004). The binding of EloB
and EloC to the SOCS-box could enhance the folding of full-length Vif in Escherichia coli
(Wang et al., 2013). The C-terminus of EloB plays key roles in the folding and function of Vif,
and therefore, if even part of those proteins are missing this could affect the VCBC-Cul5
complex from breaking down APOBEC proteins.
To investigate it further, MD simulations were run to compare the different
conformations each exhibits and the amount of conformational sampling. To run MD
simulations, the crystal structure was used for the starting structure with some alterations
depending on the simulations need to be run(Guo et al., 2014). We decided to run simulations of
VCBC with the 16 residues on the C-terminus of EloB (VCBC) and without the 16 residues
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(VCBC truncated). Running simulations on both structures also allows us to more directly
compare our experimental results to our computational analysis since the structures will be
exactly the same. Our primary analysis of global motions was done using Principle Component
Analysis (PCA). This analysis allows us to find relationships and patters in our protein complex
movements that would be invisible form a pure visual examination. When applied to MD
simulations, it detects global correlated motions of the systems which are called the principle
components. PCA splits the configurational space into 2 sub-spaces; essential and irrelevant. The
essential subspace consists of the correlated motions and are functionally important. The
irrelevant subspace is all the independent, constrained fluctuations that act locally. By using
PCA, the overall conformation changes and correlated motions of the VCBC complex with the
full-length EloB C-terminus can be compared to the conformational changes of VCBC with the
shorter EloB tail.
First, a covariance matrix is made to separate the essential motions to the irrelevant
motions that define the subspaces. Covariance is the measurement of the degree that two random
variables change together in a correlated or uncorrelated manor. The following equation is used
to build the matrix to compare all α-Carbons to subsequent α-Carbons through the simulations.

𝐶𝑜𝑣 (𝐴, 𝐵) =

̅̅̅𝑖 −𝐴)∗(𝐵
̅̅̅𝑖 −𝐵)
∑𝑛(𝐴
𝑛

1

where Ai –Ā is the change in x, y, or z coordinates of α-Carbon from initial position to time
averaged position and Bi- B is the change in x, y, or z coordinates of another α-Carbon from
initial position to time averaged position. The correlated degrees of freedom movement can be
either positive or negative. If the value found is zero, then the movements are independent and
placed into the irrelevant subspace. Then we diagonalize the Covariance matrix (M) and using
the following equation.

𝑀𝑣 = 𝜆𝑣

2

where M represents the covariance matrix, find v, the eigenvector, and λ, the eigenvalue. The
eigenvector is a metric of the correlated displacement of groups of C through space. The
eigenvalues, which are also called the principle components (PCs), represent the relationship
between the dimensions of eigenvectors. The larger the eigenvalue, the more simulation time the
eigenvector motion is capturing. The essential dynamics (ED) are the small number of principal
components that describe most of the total changes in the atoms of the proteins. They are usually
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the top three or five eigenvalues. The ED are important for studying large conformational
changes in a protein complexs (Skjaeven et al., 2010).

Methods
MD Simulations
The sequence of Vif-CBF-- EloB- EloC with the full-length Elongin B (residues 1 to
118) was used to run 8 simulations. The starting structure came from two crystal structures. The
main structure for Vif, CBF-, EloC and residues 1-78 of EloB was taken from the crystal
structure (4N9F) with Cullin 5 removed (Guo et al., 2014). The structures of residue 79-118
came from a crystal structure of the HIV Vif SOCS-box of EloBC, 2MA9 (Lu et al., 2013). To
combine the two structures, residues 1-78 of EloB were aligned in the two structures using
Visual Molecular Dynamics (VMD) (Case et al., 2016), and residues 79-102 of EloB from 4N9F
were replaced with residues 79-118 of EloB from 2MA9. We then run simulations on this
combined VCBC structure with the full-length EloB C-terminus (VCBC).
To set up the simulation, the new combined PDB to of VCBC was read into AMBER,
and the force field and water models were chosen. AMBER99sb is a force field that is
commonly used for IDPs as it has been consistent with experimental and the water model TIP3P
works well with this force field (Rauscher et al., 2015). The Amber99sb force field (Case et al.,
2016) and the TIP3P water model (Hornak et al., 2006) were used to perform simulations to stay
consistent with previous simulations run in the lab as well. Amber was used to complete MD
simulations and some analysis (Case et al., 2016). The force field defines the potential energy for
all the atoms. When each atom moves, there will be a change of forces acting on the atoms and
therefore the calculations needed were completed every femtosecond. This determines how the
atoms move in accordance with the atoms around it. Two sets of tleap were run to make sure the
format of the PDB file was compatible to use for simulations first and then to set up the
simulations. During the second tleap, a parameter file and an input coordinate file are made
based on the PDB file. The parameter files contain all information about the protein complex that
doesn’t change throughout the simulations, like the atom structure of each residue, the charge of
each residue, the order of amino acids in the protein chain. The input coordinate file contains the
starting Cartesian coordinates for all atoms in the protein structure. Then, a water box is made
around the protein and filled with water. Two more parameter and input coordinate files are
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made that include all water atoms. Next energy minimization is completed twice; first the protein
is restrained to allow the solvent to minimize to the lowest potential energy state and a second
minimization without the protein restrained so that the protein structure minimizes to its lowest
potential energy state. The first time was with restraints on the protein set to 500kcal/mol with a
1000 steps steep decent followed by a 1000 steps of gradient minimization. The second time was
without the restrained protein set to 10 kcal/mol to allow the protein to adjust to its minimization
state without having the water molecules disturb the protein movements the same steps of steep
decent and gradient minimization. Next the system is heated up mimic host cell body conditions.
The box was heated up from 0 to 300 K completed in 20 ps with the protein restraints set to 10.0
kcal/mol. Two steps of equilibration are done first with the protein restrained and then without.
The first equilibration is kept at a constant density with random velocity set with the protein
restrained to allow the solvent to equilibrate to the pressure and temperatures. The first
equilibration is done with the protein restrained at 1.0 kcal/mol over 20ps. Then the next
equilibration step allows the protein conformation to equilibrate to the constant pressure before
running the simulations. Then the simulations are begun and multiple independent simulations
can be run at once. Traditional MD was used and a total of 600 ns was achieved for each of the
8 independent simulations for a total of 4800 ns of simulation. These simulations with the full
length EloB tail were compared to previous simulations with the truncated EloB tail to see if
there is a difference in the overall conformational ensemble.

Structural and Trajectory analysis
Analysis of the molecular dynamics simulations were performed using the cpptraj
module of Amber (Case et al., 2016), and in-house python scripts. Interatomic distances, rootmean-squared-deviations (RMSD) of protein structures, root-mean-squared fluctuations, and
cpptraj (Case et al., 2016). Analysis was completed on all 8 independent simulations and the last
300 ns.

Atomic Fluctuations
To look at more local conformational sampling, we measured the atomic fluctuations of
each protein. The atomic fluctuations were calculated using the cpptraj module of Amber (Case
et al., 2016). Before calculating the fluctuations, each protein was aligned independently using
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RMSD so that the atomic fluctuations measured only represented local motions of each protein.
The root mean squared fluctuations (RMSF) measured the flexibility of each residue throughout
the simulations and shows which areas are more stable possibly due to interactions with other
proteins of confinement of movement due to the placement of other proteins.

√〈∆𝑟 2 〉

5

where r is a three-dimensional position vector such that

〈Δr 2〉 = 〈Δx 2 + Δy 2 + Δz 2〉

6

The atomic fluctuations were calculated for VCBC with and without the full-length EloB
and graphed using python onto separate plots.

Principle Component Analysis
PCA was completed using the cpptraj module of Amber (Case et al., 2016).
To prepare for PCA, all flexible loops and tail were removed from the structure so that
they would not be considered in the grouping of correlated motions. So that the rotation of the
entire protein was not considered and only movement of the protein relative to itself were used,
root-mean-squared-deviation (RMSD) was used to align all the atoms on top of each other for
every frame. The average of all structures in the trajectory was used as the reference.
Cartesian coordinates of the C position for each residue in the structured regions of the VCBC
and VCBC with the truncated tail complexes (excluding flexible tails and loops). Three
covariance matrixes were made to find different eigenvectors and eigenvalues. The first
covariance matrix was from the VCBC truncated, the second from VCBC, and the third from
both VCBC truncated and VCBC. Both sets of simulations were projected onto the different PCs
to compare the global motions of the VCBC complex.
Histogram plots were made to view the spread of conformations sampled along each
principle component through in-house python scripts. The resulting three sets of PCs with VCBC
truncated and VCBC were compared to one another.
To compare the principal components from the VCBC truncated to the newly calculated
principal components of VCBC, the overlap between the eigenvectors for the different proteins
were compared. First the coordinates were normalized
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𝑎

𝑎 = ∑𝑛
𝑖

𝑎𝑖2

3

where a is each x, y, and z coordinate for the PC. This puts each length of the PC ranked from 0
to 1. Then, the overlap between two PC were done through the dot product of the normalized
coordinate values

𝑎 ∙ 𝑏 = ∑𝑛𝑖 𝑎𝑖 ∗ 𝑏𝑖

4

where a are the lengths of one PC and b is the lengths of the other PC. The overlap quantified the
similarity between the principal components of VCB118C and VCBC (Ozcan et al., 2013).
Results
Eight simulations were run on VCBC, each for 600 ns for a total of 4800ns of data. The
starting structure for the VCBC simulations was constructed from the combination of two PDB
files. Looking at the structure in VMD, the extra residue formed a beta-hairpin loop and
interacted with EloC but it was not seen to interact with Vif (Figure 9).

Figure 9. VCBC complex with full length tail including all 118 residues of EloB. The EloB
section in lighter blue were residues that came from a different PDB structure than the other
residues.
This additional 16 residues contained more secondary structure in the C-terminus tail.
This additional structure is thought to be the reason for the difference in NMR signals because
the primary structural change lead to an increase in secondary structure which can affect the
overall stability of the protein complex.
We looked at the atomic fluctuations of the backbone in EloB and EloC. We decided to
look at EloC because the beta-hairpin loop of the C-terminus tail looked as if it was interacting
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with EloC. The backbone atomic fluctuations of 4 independent simulations of VCBC and VCBC
truncated were compared to see if there were any changes in flexibility with the addition of the
16 residues (Figure 10). The extra residues in EloB causes a decrease in flexibility of the Cterminus tail. With the truncated tail, the atomic fluctuations were much higher than any other
residues in EloB.

A)

B)

Figure 10. Atomic fluctuations of (A) EloB residues and (B) EloC residues. The atomic
fluctuations of t VCBC complex (blue) and with VCBC truncated complex (pink). Analysis
completed on the last 300ns of 4 independent simulations.
This decrease in atomic fluctuations in the C-terminus of EloB was predicted because of
the increase in secondary structure seen in the PDB made. The increase in structure decreases the
flexibility and fluctuation of the tail. However, we expected to see a difference in the atomic
fluctuations in EloC because in the PDB structure, there was a -hairpin loop that interacted with
EloC. We assumed that there would be a decrease in fluctuations where EloB was interacting
with EloC; however, there is no difference observed between the two structures of EloC.
Afterward we looked at the simulations in Visual Molecular Dynamics (VMD) a molecular
visualization program for displaying large biomolecular system using 3-D graphics, we saw that
the -hairpin loop was not conserved during the simulation. It only stayed for the first couple of
snapshots before the tail moved further away from EloC to a distance where EloB and EloC were
no longer interacting along the EloB C-terminus tail.
PCA was completed on each of the simulations and the first eigenvalues captured more
of the global correlated motions. The histograms for the VCBC and VCBC truncated
individual eigenvectors did not give good results (Supplemental Section: Figure A). We
expected to see more variation along the eigenvector for the simulations that were used to
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create the eigenvectors. For example, we thought that the VCBC truncated would have larger
range of correlated motions along its eigenvector compare to VCBC. However, this was not the
case for any of the projections. We also tried to split them up by individual simulation, but still
did not see what we expected. Then we compared the overlap between the two eigenvalues.
The overlap between VCBC and VCBC truncated PCs were calculated to see how similar or
different their global motions were. The higher values represented more overlap between the
PCs (Table 2).

Table 2. Overlap of VCBC with full length tail (VCB118C) and VCBC PCs which are not the
same PC for each construct.

VCBC PCs
VCBC truncated
PCs
1
2
3
4

1

2

3

4

49.97
52.69
10.13
1.73

-20.73
16.71
-28.01
1.27

39.82
-24.76
-9.83
13.85

15.27
-12.36
-12.23
-31.56

The highest overlap is VCBC PC1 compared to VCBC truncated PC1 and PC2. The
overlap can tell us whether the ED are similar. PC1 of VCBC truncated and PC1 of VCBC
overlap can show us that the ED of VCBC and VCBC truncated are similar. This significant
overlap shows that both constructs are sampling similar ED and degrees of global correlated
motions.
We also found the eigenvalues based on both the full length and truncated VCBC
eigenvectors and projected the snapshots of the simulations on to the eigenvectors. PC1
represents a clamshell opening and closing (Figure 10). PC2 represents an inward and outward
twist of EloB and EloC compare to Vif and CBF-. These motions hinge from Vif linker
region, connects the / domain and the  domain. Overall conformational sampling between
the two structures were relatively similar. The conformations that both complexes exhibited
were far from the crystal structure along both PC1 and PC2.
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PC2
Figure 10. PCA of VCBC with and without the full-length EloB tail ensembles. PC1 (43%)
shows a clamshell opening and closing motion. PC2 (17.6%) represents an inward and outward
twist of EloBC and Vif and CBF-
Both structures sampled about same degree of conformations along PC1 and PC2.
Along PC1, the VCBC truncated complex has slightly wider open clamshell conformations
than VCBC. From the PCA, it is seen that there are no major changes in global conformations
when adding in the 16 residues. Explaining and viewing PCA can be difficult for students who
are not familiar with how they are formed and what form of measurement it is. It can be
beneficial for readers to have another variable related to PCA to grasp what is being compared.
Along PC1, the clamshell motion, when the protein complex is in a more closed conformation
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some residues are a lot closer together than when the protein complex is in the open clamshell
conformations. Using this residue to residue distance is used as another metric to distinguish
different conformations.
We found two residues of interest that seemed to be getting closer and interacting when
the clamshell motion was closed and not interacting when the clamshell motion was more open.
We used contact maps to find which residues were the closest between EloC and CBF-. From,
the contact map, it seemed like EloC residue 68 and CBF- residue 15 were more in contact in
the open conformation (Supplemental Section: Figure B). There is a difference in the distance
between EloC68 and CBF-15 that is sampled by the different VCBC constrcuts when
comparing 4 sindependent simulations from each(Figure 11).The residues that change distance
with PC1, also change their orientations toward each other throughout the simulations.

(A)

(B)

(C)
(D)
Figure 11. Interatomic Distances between residues 310 and 528 which correspond to residue 68
of ELoC and residue 15 of CBF-. (A) Figure of when the two residues are the closer than 4
angstroms and interacting. (B) Figure when the two residues are apart and no longer interacting.
Distances between EloC and CDB-b in VCBC truncated (C) and VCBC complex (D).
From these two graphs, we were looking for some correlation between the distance
between these residues and the PC1 for VCBCtruncated and VCBC. VCBC truncated samples a
distance around 7-15 angstroms for a majority of the simulations and the distance can be as large
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as 28 angstroms. For VCBC, the favorable distance is at 5 angstroms and the largest distance it
get to is around 18 angstroms. The other four simulations of VCBC showed even more of a
preference for 5 angtroms and less sampling of simulation time of larger distances (Supplemental
Section: Figure C) . We were able to observe that without the full-length EloB, the complex
sampled a larger distance which agreed with what was seen on the PCA graph where the VCBC
truncated strcture extended further right along the PC1 eigenvector. This distance calculation can
help to simplify how to understand the change and extremes of conformational sampling of both
VCBC complexes along PC1. This additional method helps to compare the two VCBC
complexes and the differences and similarities between local and global conformational changes.

Discussion
One of the interactions between the EloB tail and Vif that was proposed in multiple
articles was not observed in our simulations (Lu et al., 2013 and Bergenson et al., 2010).
Binding between the PPLP motif in Vif and EloB was not observed in our simulations. The two
regions were very far apart during all of the independent simulations. Even though there were no
major changes in global conformational sampling when missing 16 residues, not including the Cterminal end residues does affect local conformation sampling and the increased structure in the
tail could possibly allow for more interactions with other proteins if it is more stable for a
favorable interaction.
There were small local conformational differences in the atomic fluctuations of the EloB
full length tail. This decrease in atomic fluctuations and increase in structure in the tail may have
helped to produce a better NMR signal since less flexibility means that there will be less
variation in signal so the average would be more accurate and therefore more peaks appeared
instead of getting lost in the noise. The VCBC complex and the VCBC truncated complex have
overall the same degree of conformational sampling on the global scale. Since both the PCA and
distance calcualtions show that the VCBC truncated has a slightly more open conformation, this
lead to a difference in NMR prectra. The larger more open conformation causes an increase in
this degree of global conformational sampling that caused more dissapearnce of peaks due to
motions on the intermediate timescale. Therefore, these 16 residues at the end of EloB can be
included all future NMR experiments and computational simulations.
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Both the decrease in atomic fluctuations and a slightly more open trucated complex could
be possible explanations for the improvement in NMR signal from a small primary structural
change of EloB in the VCBC structures. This can be done to improve the NMR signal that is
produced of differing VCBC complex and the NMR spectra of VCBC-A3F included the full
length EloB. So that our simulations can more directly be compared to the experimental data, our
lab used the full length EloB to run simulations of the VCBC complex with Cul5 and with
APOBEC.
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Chapter 4: Simulated Ensemble Completeness and Statistical Analysis
To confidently state the results we saw when comparing the VCBC complexes, we need
to know how fully the VCBC state is sampled. If the complex was not able to sample most of the
possible conformations during the amount of time the simulations were run for, then the results
from the analysis could only be preliminary results. The results would only represent a small
portion of the conformational sampling that the VCBC complex could possibly exhibit. Testing
if the simulations were run long enough is difficult because there is not definite answer in the
scientific community for how long is long enough to run computational simulations. There is no
definite way of knowing if your complex has sampled all possible conformations since we do not
know every conformational state of all proteins. The way that we can suggest that we have
sampled enough time is through looking to see if any new conformational states are being
sampled. Looking at the root-mean-squared deviation (RMSD) of a protein complex compares
the movement of the protein compare to its starting structure. If there are no large changes in the
RMSD, then it is likely that the protein is no longer sampling any new conformations that have
not already been sampled.
Also, analysis of the VCBC complex was not completed on all of the simulation time that
was run. It was however completed on the same amount of time from each simulation of all the
VCBC complex structure. To determine how many trajectories our analysis was to be on, we
need to see how long it took any of our simulations to give equilibrated analysis results. Stating
that there are differences between each simulation of VCBC alone, with Cul5, and with A3F
confidently is only possible with the use of statistical significance tests.
In PCA, the PC eigenvalues represent how much of the correlated motion is capture by
the eigenvector. By summing the first 5 PCs, we are calculating a majority of the global
correlated motions that are being sampled by the complex. The magnitude of the eigenvalue is
related to the total amount of variance caputred in the correlated motions. This can give us an
idea of the amount of global motion sampling each protein complex is exhibiting and if any new
correlated motions are being introduced later in the simulation. The higher the sum, the greater
amount of global correlated motions are occurring during the simulations. These numbers can
help identify the total amount of global motions and compare this to other simulations and
separated blocks of the same simulation to see if conformational sampling is increasing as the
simulation continues.
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To test if our simulations of different VCBC structures were significantly different from
each other and similar between independent simulations, a Sigma-R plot was applied. The
Sigma-r plot is of the standard deviation of intermolecular distances as a function of the
distances (Zhou et al., 2015). The standard deviations (σ) were calculated for all interatomic
distances(r) and then averaged within intervals with step size ∆𝑟, to determine the average σ for
the inter-atominc distance interval. Using the following equation
𝜎𝑟 =

1
𝑁

∑ 𝜎𝑖,𝑗

5

Where N is the number of inter atomic distances within the interval 𝑟 −

∆𝑟
2

< 𝑟𝑖,𝑗 ≤ 𝑟 +

∆𝑟
2

. The

symbols 𝑟𝑖,𝑗 stands for the mean interatomic distance and 𝜎𝑖,𝑖 stands for the mean standard
deviation of the distance between atoms I and j over the entire trajectory (Zou et al., 2015). The
sigma-r plots illustrate the average range of motion of all the interatomic distances. This
measures the average range of motion between all atoms within a protein complex. It is able to
differentiate between macromolecules that have different domain structures, molecular weight,
and single amino acid replacements. This is a way to differentiate global dynamics in a simplistic
manner that is easy to understand through a one-dimensional plot.
To test to see if the Principle Component Analysis of our differing structures were
significantly different, we applied the Kolomogorov-Sminoff (KS) test. This test was applied
since our data does not have normal distribution and so a regular t-test could not be applied
(Wasserman, 2003). This test was used in python after the PCA were split by independent
simulations.

Methods
RMSD and Radius of gyration
Sampling completeness was determined by comparing the four different simulations.
RMSD is the measure of the deviation of the molecular internal coordinates deviation from the
starting structure which was the crystal structure for some simulations. Analysis of sampling
completeness was done using the ptraj module in the Amber package and graphs were made in
python (Case et al., 2016). The RMSD of each simulation was compared
∑𝑖 𝑑𝑖2

𝑅𝑀𝑆𝐷 = √

𝑛
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where d was the distance between each of the n pairs of equivalent atoms from two structures.
The RMSD of all the simulations should be similar overtime to show that it is likely that most of
the conformational sampling of the protein complex has occurred during the elapsed time. The
radius of gyration in each simulation was calculated as well
∑𝑖 𝑚𝑖 𝑟𝑖2

𝑅𝑔𝑦𝑟 = √

∑ 𝑚𝑖

7

where ri was the distance of an atom from the center of mass of the protein and mi is the mass of
the protein. The running average of both RMSD and radius of gyration was taken. As the average
of each simulation converged over time, the distance between the atoms and the movement of the
protein relative to its center of mass has no conformational changes. If all the independent
simulations average RMSD and radius of gyrations converge, this would indicate that enough
simulations had been run. This shows that the protein is no longer sampling new conformations
that are very different from conformations that have already been sampled.

Blocks of PCA
To compare the amount of global conformational sampling between simulations and
within a simulation,PCA analysis was completed on every 100-ns blocks of every simulation for
VCBC runcated, VCBC, VCBC-Cul5, and VCBC-A3F. The PCs total of the first 5 PCs was
taken for every 100-ns blck of simulation. The sum of the top five PCs were graphed to show
how the sum equilibrated as the simulation time increased using python in-house scripts.

Sigma-R
Sigma-r plots were based off of Zhou et al. methods. The distance between each pair of
residues was calculated for all trajectories in 100-ns blocks for VCBC, VCBC-Cul5, and VCBCA3F simulations. A python script was used to calculate the standard deviation of all the distances
for each pair of electrons. The distances were binned into integers and the standard deviation for
each distance bin was taken. Then the binned distance and average standard deviation was
plotted.
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PCA of VCBC and VCBC-Cul5
PCA was completed using cpptraj module of Amber (Case et al., 2016). Cartesian
coordinates of the C position for each residue in the structured regions of the VCBC and
VCBC-Cul5 (excluding flexible tails and loops). The covariance matrix was made from VCBC
and VCBC-Cul5 trajectories. Both sets of simulations were projected onto PCs to compare the
global motions of the VCBC complex with and without Cul5. The first two PCs were viewed in
VMD and characterized with snapshots of the extreme values. They were also plotted together to
examine the global conformational sampling with and without Cul5.

Kolmogorov-Smirnoff test
For PCA, the trajectories were projected onto the eigenvectors and were averaged for
each independent simulation. We compared the 8 simulations of one construct to the 8
simulations of another construct The p-value between the constructs VCBC, VCBC truncated,
VCBC-Cul5, VCBC-A3F PCA were calculated.

Results
The RMSD values of the four VCBC with the full-length EloB tail simulations were
similar for all simulations (Figure 2). Since this value measures the deviations from the average
structure and the RMSD is within the same range, this shows that it is likely each protein
complex in the simulations are exhibiting the same range of conformational sampling.

Figure 12. RMSD of the eight simulations represented by different colors showing how similar
the structure is to the crystal structure and the other simulations.
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The running average of RMSD and the radius of gyration were used to see if the
simulation has been run long enough. The running average of RMSD measures the average
distance between the atoms and of the four simulations, it shows that there were some major
changes in that over time, as new conformations are being sampled (Figure 13A). In all
simulations, there seems to be convergence to a similar value. The running average of the radius
of gyration between the four simulations shows convergence as the simulations time increases
(Figure 13B). This shows that the simulations have likely been run for adequate amount of time.

(A)

(B)

Figure 13. (A) Running Average of RMSD measurements of the 8 VCBC simulations
(B) Running Average of the Radius of Gyration of 4 VCBC simulations. Each colored line
represents an independent simulation.
To look at the global conformational motions for the constrcut simulations, the sum of
the first five PCs of the PCA completed on 100-ns blocks was graphed to observe any change in
this sum as the simulation time increased. For the VCBC simulations, both sets of 4 simulation
showed a gradual increase in total eigenvales in the beginning but leveled off as the simulation
time continued. The VCBC-Cul5 simlations had lower total eignevalues than VCBC simulations
and remained relatively the same as the simulations time increased. The VCBC truncated began
with very high eigenvaue totals but the last 300 ns of simulation, the PC totals seems to level off.
The last 300 ns for most simulations have similar 100-ns block total PC values except for the
VCBC-A3F simulations (Figure 14). More simulation time is necessary to see if the total
eigenvalues equilibrate as the simulations are continued for the VCBC-A3F construct.
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Figure 14. Comparison of summation of first 5 eigenvalues where each line represnts 4
independent simulations.
Testing that the simulated ensemble has been sufficiently sampled is important for
simulations because you want to be able to sample as many if not all possible conformations that
the protein would exhibit experimentally. Therefore, if the simulations were not run long enough,
then not all conformations would be seen in the simulation. As the eigenvalues level out, this
indicates that there are no new major conformations appearing that would change what the total
sum of eigenvalues would be. It was decided that all analysis would be on the last 300 ns of the
simulation time run for all the simulations because the sum of the eigenvalues were similar for
the last three 100-ns blocks showing there is the same amount of variance caputred in the
correlated motions.
Sigma-R was completed for each 100-ns block and compared between the different
simulated constructs. Sigma-R was run on the last 300 ns for VCBC, VCBC-A3F, and VCBCCul5 and graphed for 100 ns of one simulation of each construct. Twelve plots in total were
made (Supplemental Section Figure D). We also graphed 100 ns of all simulations for one
construct on one plot to compare the simulations to check consistency of simulations each
construct (Figure 15). When comparing similar between constructs. VCBC Sigma-R plots show
a relatively gradual increase in mean standard deviation as the distance (r) increases. For the
VCBC-Cul5 plot there is a large increase and fluctuation of mean standard deviation for all
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simulation time beginning around 70 angstroms. Before that the standard deviation is much
lower overall compare to VCBC and VCBC-A3F. There is less of a linear relationship between
standard deviation and the distance in the VCBC-Cul5 simulations. In the VCBC-A3F
simulations, smaller standard deviations compare to VCBC, and there is more of a linear slope
for most of the data. From these plots, different trends seem to appear between constructs.

(A)

(B)

(C)
Figure 15. Sigma-R plot of the last 300ns of simulations split into 100-ns blocks. (A) VCBC
100-ns blocks of simulations from the 300ns into the simulation (B) VCBC-Cul5 100-ns blocks
of simulations beginning from 100ns into the simulation (C) VCBC-A3F 100-ns blocks of
simulation beginning from 100ns into the simulation
From the Sigma-R plots, simulation time can be evaluated to test if each construct has
had enough tie to sample through all of its corresponding free energy landscape and sample all
possible conformations. All simulations of VCBC and VCBC-Cul5 have been run long enough
that the constructs are behaving similar in each block. The sigma-r plot of last 100-ns block of
VCBC-A3F has larger variation from the normal trends seen showing that there are differences
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within the independent simulations and as simulation time increase. There is more variation of
the VCBC-A3F construct between the 100-ns blocks and therefore it is likely the simulations
need to be run longer.
We performed PCA on VCBC and VCBC-Cul5 combined to form the eigenvectors to
compare the global conformational sampling changes when Cul5 is bound to the VCBC complex
and the VCBC truncated complex. The PCs were visualized in VMD to show the primary
motions that are sampled by the VCBC-Cul5 and VCBC complex (Supplemental Section Figure
E). The first PC shows an opposing twist of Vif and CBF- in relation to EloB and EloC. The
second PC illustrates a clamshell opening motion. Both movements depend on the hinge motion
of the Vif linker region. On the PC1 vs PC2 plots, there is variation of the constructs global
conformational sampling (Figure 17).

Figure 17. Plots of PC1 vs PC2 made through projecting VCBC truncated, VCBC, VCBC-A3F,
and VCBC-Cul5 trajectories onto the PCs constructed from VCBC and VCBC-Cul5.
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The VCBC truncated and VCBC graphs show similar global conformations being
sampling along both PC1 and PC2. However, VCBC-Cul5 samples conformations that are more
similar to the crystal structure. Both VCBC constructs sample alternate conformations that are
not exhibited by VCBC-Cul5. This also shows that VCBC-Cul5 is less flexible as a complex
compare to VCBC since less conformations along the extreme ends of the PCs are being
sampled.
Even though visually the difference between VCBC and VCBC-Cul5 PCA are different,
we need to test if the difference is statically significant. P-values found for KS test showed that
the VCBC and VCBC-Cul5 PCA were statistically significant (Table 3). VCBC and VCBC-Cul5
have significantly different global conformational sampling for both PC1 and PC2 (p-value
<0.05). The same is seen for VCBC compare to VCBC-A3F (p-value <0.05). However, between
VCBC-Cul5 and VCBC-A3F, only PC1 is significantly different from each other. Also on the
VCBC/VCBC-Cul5 eigenvectors, VCBC and VCBC truncated are significantly different (pvalue < 0.5). When we looked at the PC plots, visually VCBC truncated and VCBC looks
similar. But by looking at the PCs from when VCBC truncated and VCBC form the covariance
matrix, PC2 does show that two were not significantly different (P-value >0.05).

Table 3. P-values from Kolmogorov-Smirnoff test on PCA from the VCBC and VCBC-Cul5
combined eigenvectors and from the VCBC truncated and VCBC combined eigenvectors. PC1
and PC2 are different from the two different constructions of eigenvectors and therefore cannot
be compared directly.
Construction
VCBC/VCBC
of
VCBC/VCBC-Cul5 eigenvectors
truncated
eigenvectors
eigenvectors
VCBCVCBC/
VCBC/
VCBC/
VCBC/VCBCTrajectories
Cul5/
VCBCVCBC-Cul5 VCBC-A3F
truncated
VCBC-A3F truncated
PC1
0.0496
0.0378
0.0125
0.0026
0.0481
PC2
0.0097
0.0125
0.1502
0.0125
0.3788
Overall PC1 captures more of the overall variance of the conformations of VCBC with
and without Cul5 but PC2 is more informative of which simulations are similar or different. The
p-values for both PCs of VCBC compared to VCBC-Cul5 are lower than 0.05, as expected.
There were differences between PC1 and PC2 p-values that were not expected. It is hard to make
conclusions about the PCA between the other structures for the eigenvectors were found from
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VCBC full length EloB and VCBC-Cul5 simulations together and not from VCBC-A3F or
VCBC simulations.
This led us to compare the VCBC and VCBC truncated PCA when the eigenvectors were
made from these two constructs. Along PC1 the two constructs are significantly different but
PC2 is the same for both. The magnitude of the p-value for PC2 was very high and not close to
0.05 showing that PCA of VCBC truncated and VCBC were not significantly different. This is
what we expected to see through the KS test of the PC for PC2 however, for PC1 this was
unexpected. The magnitude of the difference in PC1 showed that difference between the two
constructs was minor. Overall this shows that both these constructs sample the global motions
widely and they have similar global conformational sampling.

Discussion
We can only draw strong conclusions about differences between complexes if there is a
statistically reproducible trend. To test if the simulations were run for a long enough time that
the constructs had time to sample most if not all possible conformations, RMSD and radius of
gyration were recorded for the VCBC simulations. By observing the running average of the two
variables, we can conclude that our simulations have been run for long enough for most
conformational sampling to occur within our protein complex.
To measure how much of the simulations should be used in our analysis, spliting up the
PCA of each construct into 100-ns blocks, we were able to see how long it took for the total PCs
to equilibrate. Since the magnitude of the eigenvalue is related to the total amount of variance
captured in the correlated motions, the total of the PCs represent most of the global correlated
motions for the protein complex. Overall the last 300 ns of each construct’s simulations except
for the VCBC-A3F contain relatively the same sum of the first 5 PC values and so this set of
simulations were used in all analysis methods. This also suggests that VCBC-A3F simulations
need to be run longer to hopfully observe similar PC variance within 100-ns blocks.
From the Sigma-r plots, each of the constructs shows different trends of the mean
standard deviation as a function of interatomic distances between the VCBC, VCBC-Cul5, and
VCBC-A3F constructs. Overall the plots for simualtions of VCBC and VCBC-Cul5 showed
similar trend among their independent simualtions. This test indicates a difference between
VCBC and VCBC-Cul5 independent simualtions and that these simulations have been run for
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enough time. They also show that the simualtions have been However, for VCBC-A3F we
observed that more simulation time needs to be run.
Looking at the KS p-values of the first two PCs comparison between VCBC truncated,
VCBC, VCBC-Cul5 and VCBC-A3F demonstrated that VCBC and VCBC-Cul5 PCs from the
VCBC and VCBC-Cul5 combined eignevectors were significantly different. When comparing
VCBC truncated and VCBC PCs from the corresponding combined eigenvectors, the PC1 was
significantly different between the two constrcuts and PC2 were not singnificantly different. This
method can be best used to show the difference between two construct PCs but not how similar.
The difference between VCBC and VCBC-truncated for PC1 is not a large difference as the
magnitude of the PC1 difference is small. This supports what we visually saw with the PC plots
that they both sample these global motions widely, although there may be a slight differnce in
the way they are sampled.
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Chapter 5: VCBC with mutation in Vif N-terminus
Once we have a general understanding of the VCBC complex, the next step is to try
mutating the VCBC complex to see what residues are crucial for protein-protein interactions or
specific conformational states. By making mutations that affect binding of proteins or change the
favored conformational state for VCBC-Cul5 binding to APOBEC, we can make progress
toward a possible therapeutic target. Cul5 is a protein of the VCBC-Cul5 complex that is crucial
for the breakdown of APOBEC. Cul5 is a host cell protein that is part of host cell E3 ubiquitin
ligase complexes when the body is not infected with HIV. However, Cul5 is not necessary for
Vif to fold and bind to CBf-B, EloB, and EloC. When Cul5 binds to the VCBC complex, it may
be able to stabilize it into a conformation that is favorable for binding to APOBEC. Cul5 is also
responsible for attaching the ubiquitin protein to APOBEC, which tags the APOBEC for
degradation. When Cul5 is not bound to the VCBC complex, the complex is more flexible and
samples more conformational states (Nakashima et al., 2015). Other research completed by our
lab has been on VCBC with and without Cul5. Simulations have been run and when comparing
the PCA, VCBC-Cul5 does not exhibit alternate conformational that differ from the crystal
structure like VCBC does. The addition of Cul5 decreases global conformational sampling and
understanding what can cause a change in Cul5 interactions with the VCBC complex could
affect how we can stop the degradation of APOBEC. Cul5 binds to Vif at helix α3, the following
flexible loop of residues 116-131, and the HCCH motif which coordinates the zinc ion (Guo et
al., 2014). The conformation of the VCBC complex with Cul5 and without are studied in our lab
for insight into the structural stability which will affect how the complex functions. Making a
mutation to Vif could perturb the conformations of the VCBC-Cul5 complex which could lead to
a method of halting the breakdown of APOBEC.
Characterizing conformational sampling of the VCBC complex is crucial to understanding
how Vif recruits substrate proteins and targets APOBEC and can lead toward development of
therapeutics to prevent antiviral degradation. A way to test areas of Vif’s structure that are
functionally important is to mutate residues in motifs of the proteins. Evans et al. stated that the
N-terminal motif of Vif is important for the binding of Cul5 and therefore degradation of
APOBEC. In their experiments they performed single alanine replacement of residues 25
through 30 of Vif. The mutations in the 25-30 region reduced the ability for Vif to bind to Cul5
but didn’t affect CBF-β or EloBC binding and the mutations did not affect the structure of the
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protein complex according to their circular dichroism spectroscopy and size-exclusion
chromatography (Evans et al., 2014). This could lead to a possible target for HIV pharmaceutical
designs because if Vif and Cul5 do not bind then the APOBEC proteins cannot be ubiquitinated.
The Vif mutants L24A and V25A both inhibit Vif’s ability to degrade A3G and A3F (Evans et
al., 2014). The V25A mutation results in a 90-fold lower binding affinity to Cul5. Lowering the
binding affinity of Vif and Cul5 could help decrease the probability of the whole VCBC-CUl5
complex binding together and therefore APOBEC proteins would not be tagged with ubiquitin to
be degraded. To look at the effects of the V25A mutation on the VCBC complex (mutant
VCBC), we ran MD to test the effect of a single point mutation at the N-terminus of Vif on the
C-terminus of Vif, which is where Cul5 and EloBC bind to Vif.

Figure 18. Vif with mutation of Valine to an alanine at residue 25 which is highlight in magenta
Methods
MD Simulations
MD simulations were run in similar manner as the VCB118C complex simulations. Four
independent simulations were run for 100ns each to allow for preliminary analysis. Residue 25 in
Vif, a valine, was mutated to an alanine by editing the PDB file. Two carbons and the bonded
hydrogens were removed from the side chain of the valine to make it into an alanine. Tleap was
run to check the PDB file format, and optimize the location of the atoms of the new alanine
residue. The two TER were taken out of Vif so there were no breaks in the Vif sequence. A
second tleap was run subsequently for Amber to reformat the PDB file, add water and ions to the
simulations, put in the water box size for the protein, and make the parameter topology and input
coordinate files.
Minimization was completed twice; once, with restraints on the protein set to
500kcal/mol with a 1000-steps steep decent followed by a 1000-steps of gradient minimization
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and the second time was without the restrained protein with restraints only set to 10 kcal/mol to
allow the protein to adjust to its minimization state without having the water molecules disturb
the protein movements. The box temp increases from 0 to 300 K completed in 20 ps with the
protein restraints set to 10.0 kcal/mol. Then, two equilibration steps are completed to equilibrate
the density of the simulations. The first equilibration is done with the protein restrained at 1.0
kcal/mol over 20ps. The simulations were run at 300 K. Traditional MD was used and a total of
300 ns was achieved for each of the 4 independent simulations for a total of 1200 ns of
simulation.

Analysis Methods
Analysis was completed on 300 ns each for 4 independent simulations. RMSD and radius
of gyration were used to determine sample completeness (Chapter 4 methods). Atomic
fluctuations were calculated to look at local conformational perturbation to residue flexibility
(Chapter 3 methods). Principle Component Analysis was also used to look at any changes in
global conformational sampling (Chapter 3 methods).

PCA of VCBC and VCBC-Cul5 with Mutant VCBC
PCA was completed using cpptraj module of Amber (Case et al., 2016). Cartesian
coordinates of the C position for each residue in the structured regions of the VCBC and
VCBC-Cul5 (excluding flexible tails and loops) were used to make the covariance matrix.
Mutant VCBC trajectories were projected onto PCs to compare the global motions of the VCBC
complex with and without Cul5. The first two PCs were viewed in VMD and characterized with
snapshots of the extreme values. They were also plotted together to examine the global
conformational sampling with and without Cul5.

Results and Discussion
Since each of the four independent simulations have run for only 300 ns each, all of the
data is preliminary results. RMSD is the deviation of the molecular internal coordinates from the
starting structure. The RMSD and Radius of gyration of all the simulations should be similar
overtime to show that it is likely that most of the conformational sampling of the protein
complex has occurred during the elapsed time. The RMSD and radius of gyration values of the
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four mutant VCBC simulations were similar for all simulations (Figure 19 and 20). Since RMSD
measures the deviations from the average structure and appears within the same range between
simulations, it is likely each protein complex in the simulations are exhibiting the same range of
conformational sampling.

Figure 19. RMSD of VCBC with mutation

Figure 20. Radius of Gyration with mutation

Plotting the running average of these two variables is another way to test if the
simulations have been run to allow for complete conformational sampling. The running average
of RMSD of the four simulations converging to a similar value illustrates that there were some
major changes but over time less new conformations are being sampled (Figure 21A). The
running average of the radius of gyration between the four simulations shows less convergence
than the running average of the RMSD (Figure 21B).

(A)
(B)
Figure 21. Running average of the (A) RMSD and (B) radius of gyration for the four
independent simulations of the VCBC mutant.
More simulations need to be run as the running average of the radius of gyration from
each independent simulation has not converged. Eventually, all the simulations will be run for
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600 ns as this amount of time is seen to allow the VCBC complex to completely sample its free
energy landscape (Chapter 4). Also, we saw that 300 ns was used to complete all methods of
analysis in Chapter 4. A total of 600 ns was necessary for the VCBC complex to have leveling
off of running average of RMSD and radius of gyration, so to compare the results of mutant
VCBC to VCBC directly, a total of 600 ns for each mutant VCBC independent simulations needs
to be run and then of the 600 ns, analysis will need to be run on the last 300 ns of simulations.
Preliminary PCA analysis of VCBC mutant was projected onto a plot with VCBC and
VCBC-Cul5 PC1 and PC2 plot (Figure 22). From the plot, the VCBC mutant appears to be
sampling conformations more like VCBC-Cul5 conformations than VCBC.

Figure 22. Mutant VCBC, VCBC, and VCBC-Cul5 construct trajectories projected onto PC1 and
PC2 from VCBC and VCBC-Cul5 combined eigenvectors. Mutant VCBC is sampling a small
range of conformations along both PC1 and PC2 compared to VCBC.
Over time, the trajectories may move more and sample more alternate conformations
more like VCBC but this was seen very little in the first 300 ns. Because this is only analysis on
the first 300 ns, more simulation time is needed to make sure all conformational sampling can
occur to see if as the simulations continue, a wider range of conformational sampling is
exhibited. The trajectory of mutant VCBC may continue to sample closer to the crystal structure
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as the first 300 ns from 4 independent simulations appear to be doing which would imply that
mutant VCBC is sampling conformations more similar to VCBC-Cul5.
We compare atomic fluctuations between mutant VCBC, VCBC, and VCBC-Cul5 to
observe local conformational changes in different structures. Overall, the mutant VCBC Vif
protein had similar atomic fluctuations to the Vif protein in the VCBC-Cul5 simulations (Figure
22). The mutation was at residue 25 and the atomic fluctuations in the 20-30 region did not differ
very much from the VCBC atomic fluctuations. This indicates that this mutation did not have a
local conformational effect on the Vif protein in the initial simulations.

Figure 23. Atomic Fluctuations of Vif comparing between three constructs.

Figure 24. Atomic Fluctuations of EloC comparing three constructs
Cul5 binds to EloC, and as we have seen previously, when Cul5 binds to EloC there is a
large drop in atomic fluctuations of residues 30-40. There is a smaller peak of atomic
fluctuations were in this region for the mutant VCBC simulations compare to the wild-type
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VCBC simulations (Figure 24). All other regions of EloC remain relatively similar to both
VCBC and VCBC-Cul5 fluctuations. However, since the mutant VCBC simulations have only
been run for 200ns, this could be due to the atoms not fluctuating as much as possible due to the
time limit. As more simulations are run, it is likely the atomic fluctuations overall will increase
as the atoms have more time to fluctuation more. If there is no change in Vif atomic fluctuations,
then the atomic fluctuations are more similar to the VCBC-Cul5 atomic fluctuations. If in EloC
the atomic fluctuations do not increase, then in the mutant VCBC atomic fluctuations, the region
where Cul5 binds to EloC could potentially be affected by a single point mutation in Vif.

Discussion
Overall, more simulation time needs to be run to confirm all the preliminary results
between VCBC and mutant VCBC for running average of RMSD and radius of gyration, PCA,
and atomic fluctuations. From the running average of radius of gyration, more simulations time
needs to be run to allow for complete sampling of the free energy landscape. Since the VCBC
simulations were all run for 600 ns, this amount of simulation time will likely be a valid amount
of time to run simulations (Chapter 4 results). Looking at the preliminary PCA, the mutant
VCBC simulations appear to be sampling conformations close to the crystal structure and similar
to VCBC-Cul5 simulations. The experimental data on this mutant showed that the N-terminus of
Vif was important for Cul5 binding to the VCBC complex (Evans et al., 2014) Preliminary data
does indicate that the mutation we made of changing residues 25 from a valine to an alanine may
change the global conformational sampling of the VCBC and affects atomic fluctuations in EloC.
This mutation lowers the experimental binding affinity of Cul5 for EloC, and our preliminary
results show that the atomic fluctuations of residues 30-40 of EloC, where Cul5 binds, is lowered
when VCBC is mutated. This decrease in atomic fluctuations is similar to what occurs when
VCBC is bound to Cul5 in the VCBC-Cul5 atomic fluctuations.
However, again, this is all preliminary data and the mutant VCBC complex has not been
able to completely sample its free energy landscape, and therefore both the PCA and atomic
fluctuation results are likely to change. We plan to continue running our four independent
simulations as well as run more independent simulations. Future studies will look at dihedral
angles and hydrogen bond analysis to identify local conformational changes. We would also like
to look at other single point mutations in the N-terminus of Vif in the VCBC complex to learn
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more about the allosteric effect the N-terminus of Vif has on the C-terminus of Vif and other
bound proteins like EloC. Mutations help us identify which residues are important for the
conformational changes that we observe in the VCBC and VCBC-Cul5 constructs. This could
help us find a Vif point mutation that could disrupt Cul5 binding so that the E3 ubiquitin ligase
cannot be completed and therefore cannot breakdown APOBEC proteins.
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Chapter 6: Conclusion
One goal of our research and analysis of simulations was to compare the VCBC and
VCBC-Cul5 constructs. From my work and the work of the rest of the lab, we conclude that
VCBC samples alternate conformations and it samples less with Cul5 bound. To support this, we
first looked at experimental data to find differences between VCBC and VCBC-A3F since NMR
spectroscopy could not be completed on VCBC-Cul5. From those results simulations were run
on VCBC to compare analysis to VCBC-truncated and saw that there were no changes in degree
of global motion sampling and little local conformational changes. This allows us confidently to
use the full EloB sequence with the Guo et al. VCBC truncated structure even through it was not
part of the same crystal structure because it did not appear to drastically affect the global
correlated motions. We used VCBC to compare conformational sampling of VCBC-Cul5 instead
of the VCBC truncated construct. To confidently draw conclusions from our results, we ran
statistical analysis tests and tests for complete conformational sampling for each construct. Based
on these results, both VCBC and VCBC-Cul5 simulations have been run for valid lengths of time
but VCBC-A3F simulations need to be run longer. Since we know that VCBC-Cul5 samples
fewer alternate conformations than VCBC, we next tried to mutate Vif to alter the
conformational sampling of VCBC. Preliminary results from PCA show that mutant VCBC
exhibits similar conformations to VCBC-Cul5 and the atomic fluctuations of VCBC-truncated
are lower than VCBC. However, this all could be due to the mutant VCBC complex not having
enough simulation time to sample all conformations in its free energy landscape. Overall we see
that VCBC without Cul5 is more flexible and Cul5 helps to stabilize the VCBC complex to allow
for the binding and breakdown of APOBEC proteins.
NMR spectra of VCBC truncated, VCBC, and VCBC-A3F were compared. VCBC-A3F
produces a clear signal with more methyl peaks appearing due to the decrease in exchange
occurring on the intermediate time scale. We also tried to identify the different peaks that
appeared in our spectra and what type of residue they were. Using a python package called
NMRglue, I labeled peaks by protein and residues type after generalizing what type of residue
would appear in which area of the spectra. I also compared the VCBC truncated NMR spectrum
to the VCBC NMR spectrum and saw that the VCBC spectrum has a clearer signal and produced
better NMR results. Since VCBC-A3F compared to VCBC and VCBC compared to VCBC
truncated each exhibited less conformational sampling on the intermediate time scale than the
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latter, it could be that the additional protein A3F and additional residues to EloB both helped
stabilized the protein complex.
Our NMR results lead us to run MD simulations of the VCBC truncated structure, and
VCBC. We ran VCBC simulations to analyze why the NMR experimental data indicate that
small primary structural change could lead to changes in exchange on the intermediate timescale.
The atomic fluctuations showed that the full-length C-terminus tail has lower flexibility and an
increase in secondary structure making it more stable. This added stability could have helped the
NMR. PCA was used to observe global conformational sampling and does so through separating
the motions of the protein complex into correlated global motions (essential motions) and
unessential motions. Each principle component represents one global motion and PC1 showed a
clamshell opening and PCC2 showed an opposing twist. By projecting the protein complex
trajectories onto the eigenvectors, we can visualize how the protein complex is moving and the
extremes of each PC. Comparing VCBC truncated and VCBC, they exhibit about the same
degree of conformational sampling along PC1 and PC2. VCBC truncated sampled a slightly
more open clamshell motion than VCBC. Then when viewing the distance that changed with the
clamshell motion, we see that VCBC truncated samples larger distances during more of the
simulation than VCBC. This open clamshell conformation increases conformational sampling
occurrs when adding 16 residues to the end of EloB in the VCBC complex and causes an
increase in exchange on the intermediate timescale causing a decrease in peaks on the NMR
spectra. From these results, the full-length EloB was included within the VCBC-Cul5 and
VCBC-A3F constructs allowing us to have a more direct comparison to the NMR spectroscopy
results since the constructs contain the same amino acid sequences.
We used multiple statistical analysis tests to see if our results were significant and if our
simulations were run for enough time. The running average of both RMSD and radius of
gyration are used to test if our simulations of VCBC are run for enough time for the constructs to
sample completely through their free energy landscape. As the average of each simulation
converged over time for the VCBC complex, the distance between the atoms and the movement
of the protein relative to its center of mass show when they are no longer sampling new local
conformations. We used PCA on VCBC truncated, VCBC, VCBC-A3F, and VCBC-Cul5 100-ns
blocks to observe how the sum of the top 5 PCs changes as the simulations run. The last 300 ns
of all simulations gave similar variance of the global motions for VCBC, and VCBC-Cul5 and
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therefore the last 300 ns will be used for all analysis methods. However, the trends of VCBCA3F 100-ns PCs totals did not remain level showing that longer simulations would need to be
run since there was still an increase in variance of global motions occurring. Sigma-R plots made
to show that the VCBC and VCBC-Cul5 were run for enough time as well; however, the VCBCA3F simulations need to be run longer as the trends between each 100-ns block were not that
similar to each other. Each construct shows different trends of mean standard deviations of
distances as the interatomic distances increase. To test if our PCA values were significant, we
used the Kolmogorov-Smirnoff p-values to show that the projection of VCBC and VCBC-Cul5
on their combined eigenvectors is significantly different. When VCBC and VCBC truncated
trajectories are projected on their combined eigenvectors it was seen that they both exhibit a
wide range of global conformations but likely not the exact same conformations.
Mutant VCBC contains a single point mutation in Vif at residue 25. Simulations of the
valine residue mutated to an alanine are run and through running averages of radius of gyration,
we conclude that the simulations need to be run for longer since not all possible conformations
had been sampled yet from the free energy landscape. Preliminary results show through PCA and
atomic fluctuations that the VCBC mutant sampled similar degrees of global correlated motions
and local atomic flexibility to VCBC-Cul5. However, more independent simulations and
continuous simulations need to be completed before any definitive results can be concluded. This
mutation location has been seen to affect Cul5 binding and primary results do suggest that this
mutation is affecting the global and local conformations of the VCBC complex.
To continue our comparison between VCBC and VCBC-Cul5, our next steps are to
continue creating new constructs with mutations to see if the stable VCBC-Cul5 could be made
to sample more alternate conformations like VCBC or confine the complex to an unfavorable
conformation that disallows APOBEC protein from binding to Vif. Simulations are being run of
VCBC-Cul5 with the V25A point mutation and other mutations in this C-terminus region of Vif
will be run. Keeping Cul5 from binding to VCBC will keep the complex inactive and stop the
binding of APOBEC that leads to its degradation and ubiquitination. This can help lead to a
possible therapeutic target to stop the breakdown of APOBEC, which in turn would prevent HIV
from spreading through the body.
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Supplemental Information
Figure A. Evecs of individual VCBC and VCBC full length
VCBC eigenvectors:

VCB118C eigenvectors:

VCBC and VCBC118C eigenvectors:

Py script for creating histograms of the PC for VCBC, VCBC-full length eigenvectors

def histogram1(pdb, pdb_name, snapshots, snapshots_name, pc, savepath): #give where the file is located and where to
save the files
pdb_pca = pd.read_table(pdb, sep = '\s+') #read in VCBC simulation onto VCB118C evecs
snapshots_pca = pd.read_table(snapshots, sep = '\s+') #read in VCB118C simualtion onto VCB118C evecs
binedges = np.arange(snapshots_pca["Mode"+pc].min(), snapshots_pca["Mode"+pc].max(), 10)
hist1 = plt.figure()
plt.hist(snapshots_pca["Mode"+pc], bins = binedges, normed = True, color ="red", alpha = 0.5, label = snapshots_name)
#plot histogram
plt.axvline(x= pdb_pca["Mode"+pc][0], color='g', linewidth=2, label = pdb_name) # plot line onto the histogram
plt.ylabel ('Fraction of structure from simulation')
plt.xlabel ('PC'+pc)
plt.legend (loc = 'upper right')
plt.savefig(savepath)
def histogram2(pdb, pdb_name, snapshots1, snapshots1_name, snapshots2, snapshots2_name, pc, savepath): #give
where the file is located and where to save the files
pdb_pca = pd.read_table(pdb, sep = '\s+') #read in file name and VCBC_pca becomes the dataframe
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snapshots1_pca = pd.read_table(snapshots1, sep = '\s+')
snapshots2_pca = pd.read_table(snapshots2, sep = '\s+')
if snapshots1_pca["Mode"+pc].min() < snapshots2_pca["Mode"+pc].min():
min_val = snapshots1_pca["Mode"+pc].min()
else:
min_val = snapshots2_pca["Mode"+pc].min()
if snapshots1_pca["Mode"+pc].max() > snapshots2_pca["Mode"+pc].max():
max_val = snapshots1_pca["Mode"+pc].max()
else:
max_val = snapshots2_pca["Mode"+pc].max()
binedges = np.arange(min_val, max_val, 10)
hist2 = plt.figure()
plt.hist(snapshots1_pca["Mode"+ pc], bins = binedges, normed = True, color ="blue", alpha = 0.5, label =
snapshots1_name)
plt.hist(snapshots2_pca["Mode" + pc], bins = binedges, normed = True, color ="red", alpha = 0.5, label =
snapshots2_name)
plt.axvline(x = pdb_pca["Mode"+ pc][0], color='g', linewidth=2, label = pdb_name)
plt.ylabel ('Fraction of total eigenvalues')
plt.xlabel ('PC2')
plt.legend (loc = 'upper left')
plt.savefig(savepath)
def histogram3(pdb1, pdb1_name, pdb2, pdb2_name, snapshots1, snapshots1_name, snapshots2, snapshots2_name, pc,
savepath): #give where the file is located and where to save the files
pdb1_pca = pd.read_table(pdb1, sep = '\s+') #read in file name and VCBC_pca becomes the dataframe
pdb2_pca = pd.read_table(pdb2, sep = '\s+')
snapshots1_pca = pd.read_table(snapshots1, sep = '\s+')
snapshots2_pca = pd.read_table(snapshots2, sep = '\s+')
if snapshots1_pca["Mode"+pc].min() < snapshots2_pca["Mode"+pc].min():
min_val = snapshots1_pca["Mode"+pc].min()
else:
min_val = snapshots1_pca["Mode"+pc].min()
if snapshots1_pca["Mode"+pc].max() > snapshots2_pca["Mode"+pc].max():
max_val = snapshots1_pca["Mode"+pc].max()
else:
max_val = snapshots2_pca["Mode"+pc].max()
binedges = np.arange(min_val, max_val, 10)
hist2 = plt.figure()
plt.hist(snapshots1_pca["Mode"+ pc], bins = binedges, normed = True, color ="blue", alpha = 0.5, label =
snapshots1_name)
plt.hist(snapshots2_pca["Mode" + pc], bins = binedges, normed = True, color ="red", alpha = 0.5, label =
snapshots2_name)
plt.axvline(x = pdb1_pca["Mode"+ pc][0], color='g', linewidth=2, label = pdb1_name)
plt.axvline(x = pdb2_pca["Mode"+ pc][0], color='g', linewidth=2, label = pdb2_name)
plt.ylabel ('Fraction of total eigenvalues')
plt.xlabel ('PC2')
plt.legend (loc = 'upper left')
plt.savefig(savepath)
if __name__ =='__main__': #need to run frm command line
import pandas as pd #import needed modules
import sys
import numpy as np
import matplotlib.pyplot as
plt plt.switch_backend('agg') #something about not displaying in command line
if len(sys.argv) == 7:
histogram1(sys.argv[1], sys.argv[2], sys.argv[3], sys.argv[4], sys.argv[5], sys.argv[6]) #set up the parameters for what
will be inputed in command line
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elif len(sys.argv) == 9:
histogram2(sys.argv[1], sys.argv[2], sys.argv[3], sys.argv[4], sys.argv[5], sys.argv[6], sys.argv[7], sys.argv[8])
elif len(sys.argv) == 11:
histogram2(sys.argv[1], sys.argv[2], sys.argv[3], sys.argv[4], sys.argv[5], sys.argv[6], sys.argv[7], sys.argv[8],
sys.argv[9], sys.argv[10])

Figure B. Contact map between CBF- residues and EloC residues

Figure C. VCBC Simulations 5-8 distance between residues

Py script for Sigma-R
def sigma_r(filenameA, filenameB, filenameC, savepath):
maximum= 555
minimum = 1
r_matrixA = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
#makes the initial matrix of zeros for all the residue-residue contacts
sigma_matrixA = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
#makes the initial matrix of zeros for all the residue-residue contacts
r_matrixB = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
sigma_matrixB = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
r_matrixC = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
sigma_matrixC = [[0 for i in range((int(maximum)-int(minimum))+1)] for i in range((int(maximum) - int(minimum))+1)]
for x in range(int(minimum),int(maximum)):#the two for loops are used to get all the residue-residue distance files
for x2 in range(x + 1, int(maximum)+ 1):
A = pd.read_table(filenameA + str(x) + '-' + str(x2) + '.dat', sep='\s+') #reads in filenameA that
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#has x and x2 as its distance; format is filenameAx-x2.dat
A.columns = ['#Frame', 'Dis'] #renames the column names
r_matrixA[x2-int(minimum)][x-int(minimum)] = A['Dis'].mean()
sigma_matrixA[x2-int(minimum)][x-int(minimum)] = A['Dis'].std()
#make the matrix into a dataframe; make matrix into data series first; make 2D data into 1D
r_dataframeA= pd.DataFrame(r_matrixA)
sigma_dataframeA= pd.DataFrame(sigma_matrixA)
sig_rA = pd.DataFrame(columns = ['inds','r', 'sigma']) #make new empty dataframe
sig_rA["r"] = pd.Series(r_dataframeA.values.ravel('F')) #put the r_matix and sigma_matrix into sig_r dataframe
sig_rA["sigma"] = pd.Series(sigma_dataframeA.values.ravel('F')) # get them into columns; inds stay empty
bins = np.array(range(0,int(round(sig_rA['r'].max())))) #created bins based on the values in r
sig_rA['inds'] = np.digitize(sig_rA['r'], bins) #assign inds values based on r bins
sig_rA.drop(sig_rA[(sig_rA["r"] == 0)].index, inplace=True) #drops all zeros
graphdataA = pd.DataFrame(sig_rA.groupby('inds')['sigma'].mean())#takes mean of standard deviation based on bin
for x in range(int(minimum),int(maximum)):
for x2 in range(x + 1, int(maximum)+ 1):
B = pd.read_table(filenameB + str(x) + '-' + str(x2) + '.dat', sep='\s+')
B.columns = ['#Frame', 'Dis']
r_matrixB[x2-int(minimum)][x-int(minimum)] = B['Dis'].mean()
sigma_matrixB[x2-int(minimum)][x-int(minimum)] = B['Dis'].std()
r_dataframeB= pd.DataFrame(r_matrixB)
sigma_dataframeB= pd.DataFrame(sigma_matrixB)
sig_rB = pd.DataFrame(columns = ['inds','r', 'sigma'])
sig_rB["r"] = pd.Series(r_dataframeB.values.ravel('F'))
sig_rB["sigma"] = pd.Series(sigma_dataframeB.values.ravel('F'))
bins = np.array(range(0,int(round(sig_rB['r'].max()))))
for x in range(int(minimum),int(maximum)):
for x2 in range(x + 1, int(maximum)+ 1):
C = pd.read_table(filenameC + str(x) + '-' + str(x2) + '.dat', sep='\s+')
C.columns = ['#Frame', 'Dis']
r_matrixC[x2-int(minimum)][x-int(minimum)] = C['Dis'].mean()
sigma_matrixC[x2-int(minimum)][x-int(minimum)] = C['Dis'].std()
r_dataframeC= pd.DataFrame(r_matrixC)
sigma_dataframeC= pd.DataFrame(sigma_matrixC)
sig_rC = pd.DataFrame(columns = ['inds','r', 'sigma'])
sig_rC["r"] = pd.Series(r_dataframeC.values.ravel('F'))
sig_rC["sigma"] = pd.Series(sigma_dataframeC.values.ravel('F'))
bins = np.array(range(0,int(round(sig_rC['r'].max()))))
sig_rC['inds'] = np.digitize(sig_rC['r'], bins)
sig_rC.drop(sig_rC[(sig_rC["r"] == 0)].index, inplace=True)
graphdataC = pd.DataFrame(sig_rC.groupby('inds')['sigma'].mean())
plt.plot(graphdataA, label = "VCBC")
plt.plot(graphdataB, label = "VCBC-Cul5")
plt.plot(graphdataC, label = "VCBC-A3F")
plt.xlabel("r", fontsize=14)
plt.ylabel("Standard deviation", fontsize = 14)
plt.legend(loc = "upper left", fontsize = 14)
plt.savefig(savepath)
if __name__ =='__main__':
import matplotlib.pyplot as plt
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import pandas as pd
import sys
import numpy as np
plt.switch_backend('agg')
sigma_r(sys.argv[1],sys.argv[2],sys.argv[3],sys.argv[4])

Figure D. Plots for Sigma-R of individual constructs compare to each other
Sim1

Sim2

Sim 3

Sim 4
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Figure E: PCA from the Covariance Matrix made of VCBC and VCBC-Cul5 trajectories.
Illustrations of both PC1 and PC2 motions.
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